Objective Because of the lack of head-to-head trials, the aim was to indirectly compare sodium glucose transporter-2 (SGLT-2) inhibitors in the treatment of type 2 diabetes. Design Systematic review ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback